INNOVATION SUPPORTING WOMEN’S HEALTH—D3 ARRAY™-UTI.
January 31, 2024
It’s important to women and the doctors that treat them. It’s important to labs. It’s exciting for all of us at PathogenDx. As 2024 ramps up, we are proud to announce that our latest application of PathogenDx D3 Dynamic Dimensional Detection platform (visit our science page here to learn about it) is nearly ready for its formal introduction.
This new assay demonstrates our commitment to delivering diagnostic health that advances the treatment of conditions that greatly affect women. D3 Array™-UTI is our first clinical health assay, and as the name applies, it helps lab more effectively deliver insight to clinicians who are treating complex and recurrent urinary tract infections. The numbers don’t lie: more than 2.9 million women experience a UTI infection every year—and with many of these conditions actually leading to serious complications, and even mortality, the importance of this technology cannot be overstated.
Hence, the need for PathogenDx D3 Array™-UTI —an assay with the following top line benefits:
- Identifies 26 causative pathogens+12 Antibiotic Resistance Genes in a single, rapid test
- Delivers Qualitative & Quantitative Detection in the same reaction
- Provides Multiplex Quantitation across three buckets
- > 10K to <100K/cells/mL
- > 100K to 1M cells/ml
- > 1M cells/ml
- Affordable, accurate triplicate results are provides in each reaction well, with built-in positive and negative controls without utilizing extra wells.
- Greater throughput vs other UTI panels—48 samples per plate.
- Equipment Agnostic for Greater Flexibility. D3 Array™-UTI uses standard lab equipment to ease into your workflow and deliver ROI.
- Simple Reporting via an easy and intuitive cloud-based platform.
At the end of the day, PathogenDx D3 Array™-UTI delivers lower cost than other UTI testing solutions. Enjoy up to 30% less cost due to converging all targets in one well—without sizable upfront investment in equipment or extensive training time for lab staff. Reach out and we’ll be happy to provide a technical webinar on how this new assay can advance your own lab operations.
Back »